Product Information

AMLODIPINE-ATORVAST 10-80 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.5140 per EA under NDC 00378452093. Its NADAC has been published 588 times since Jul 16, 2014.

FDA first approved this application on Nov 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-ATORVAST 10-80 MG

Amlodipine and atorvastatin
$1.5140per EA

Strength

10; 80 mg/1; mg/1

NDC

00378452093

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200465

FDA Approved

11/29/2013

TE Code

AB

On Market Since

5/21/2014

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for AMLODIPINE-ATORVAST 10-80 MG has been published 588 times since Jul 16, 2014, and over the history we have for it it has declined 73.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5140 per EA
All-time high$6.9697 (Mar 11, 2015)
All-time low$1.5140 (Oct 21, 2026)
52-week high$2.1966
52-week low$1.5140
Median price$3.8099
Average price$3.8036
Largest weekly change+64.1% (Aug 23, 2017)
Weeks tracked588
Tracking sinceJul 16, 2014

Price History

1W

0.0%

1M

-3.3%

3M

-9.7%

6M

-10.2%

1Y

-30.0%

3Y

-53.3%

5Y

-60.3%

All

-73.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine and atorvastatin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-ATORVAST 10-80 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-80 MG, manufactured by Mylan Pharmaceuticals Inc., is $1.5140 per EA (NDC 00378452093), effective Nov 11, 2026.

How has the price of AMLODIPINE-ATORVAST 10-80 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has declined 73.5%. It has been tracked across 588 weekly CMS publications since Jul 16, 2014.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-80 MG?

Since Jul 16, 2014, the NADAC for AMLODIPINE-ATORVAST 10-80 MG has ranged from a low of $1.5140 (Oct 21, 2026) to a high of $6.9697 (Mar 11, 2015), with a median of $3.8099 per EA.

Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-80 MG?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-ATORVAST 10-80 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-ATORVAST 10-80 MG?

AMLODIPINE-ATORVAST 10-80 MG (NDC 00378452093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.